Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Novavax to Participate in Jefferies London Healthcare Conference

prnewswire.com

Novavax to Participate in Jefferies London Healthcare Conference GAITHERSBURG, Md., Nov. 11, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that company management will participate in the following upcoming investor conference:

A live webcast of the fireside chat will be available on the "Events & Presentations" page of the Company's website at ir.novavax.com. A replay of each webcast will be available for 30 days following the presentation.

About Novavax

Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M ® adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid™, R21/Matrix-M™), Matrix technology and research and development assets. Please visit novavax.com and LinkedIn for more information.

Contacts:

Investors

Naina Zaman

240-410-5353

[email protected]

Media

Yvonne Sprow

240-720-7804

[email protected]

SOURCE Novavax, Inc.